http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1067924-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8ec501b87b1be0fd8a239e8b64efc16 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-409 |
| filingDate | 1999-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38fbce79f8a16334dcc92ecb45f234f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_780158db3f91ad144f439fbd3ea5429a |
| publicationDate | 2001-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1067924-A1 |
| titleOfInvention | Use of a porphyrin for producing a medicine reducing the number of eosinophils |
| abstract | The invention is related to the field of chemistry and more particularly human or veterinary therapeutic chemistry. It concerns the use of zinc protoporphyrin (IX (ZnPP-IX) or one of its salts for producing a medicine designed to reduce the number or eosinophils in tissues. More particularly, ZnPP-IX is used for producing a medicine for treating pathologies related to hypereosinophilia such as bronchial asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis. |
| priorityDate | 1998-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.